| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/28/2002 | WO2002024929A2 A SOLUBLE BETA 2 MICROGLOBULIN (β2M)/HFE MONOCHAIN FOR BIOTECHNOLOGICAL AND THERAPEUTIC APPLICATIONS |
| 03/28/2002 | WO2002024927A2 Regulation of human adam-ts 1 precursor-like protein |
| 03/28/2002 | WO2002024925A2 69109, a novel human tyrosine phosphatase and uses therefor |
| 03/28/2002 | WO2002024924A2 Protein phosphatases |
| 03/28/2002 | WO2002024923A1 Polypeptide having phospholipase a2 actiivty |
| 03/28/2002 | WO2002024920A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 03/28/2002 | WO2002024912A2 Isolated nucleic acid molecules which encode a soluble il-tif/il-22 receptor or binding protein which binds to il-tif/il-22, and uses thereof |
| 03/28/2002 | WO2002024909A2 Receptor nucleic acids and polypeptides |
| 03/28/2002 | WO2002024908A1 Novel tissue-specific secretory polypeptide and dna thereof |
| 03/28/2002 | WO2002024903A1 Method of examining allergic disease |
| 03/28/2002 | WO2002024899A2 Improved system for regulation of transgene expression |
| 03/28/2002 | WO2002024895A2 Transcription factors and zinc finger proteins |
| 03/28/2002 | WO2002024893A2 CHARACTERIZATION OF THE GSK-3β PROTEIN AND METHODS OF USE THEREOF |
| 03/28/2002 | WO2002024891A2 B7-like molecules and uses thereof |
| 03/28/2002 | WO2002024889A2 Optimized cardiac contraction through differential phosphorylation of myosin |
| 03/28/2002 | WO2002024888A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/28/2002 | WO2002024887A2 Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen |
| 03/28/2002 | WO2002024886A2 Regulation of human serine protease |
| 03/28/2002 | WO2002024885A2 Regulation of human g protein-coupled receptor |
| 03/28/2002 | WO2002024884A2 Regulation of human serine palmitoyltransferase-like enzyme |
| 03/28/2002 | WO2002024883A2 Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions |
| 03/28/2002 | WO2002024877A2 Regulation of human pristanoyl-coa oxidase-like enzyme |
| 03/28/2002 | WO2002024867A2 Novel compositions and methods for lymphoma and leukemia |
| 03/28/2002 | WO2002024866A2 Method of inducing apoptosis in lymphoid cells |
| 03/28/2002 | WO2002024864A2 Antisense modulation of syntaxin 4 interacting protein expression |
| 03/28/2002 | WO2002024750A2 Human kidney tumor overexpressed membrane protein 1 |
| 03/28/2002 | WO2002024748A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/28/2002 | WO2002024746A1 Transfer factor from birds eggs |
| 03/28/2002 | WO2002024742A2 Atp-binding cassette protein |
| 03/28/2002 | WO2002024741A2 Isolated genomic polynucleotide fragments from chromosome 7 |
| 03/28/2002 | WO2002024739A2 Spas-1 cancer antigen |
| 03/28/2002 | WO2002024738A1 β-CATENIN NUCLEAR LOCALIZED PROTEIN |
| 03/28/2002 | WO2002024735A2 Peptide inhibitors of hiv entry |
| 03/28/2002 | WO2002024733A2 Human polynucleotides and polypeptides encoded thereby |
| 03/28/2002 | WO2002024732A2 Methods for improving the antagonistic/agonistic properties of peptidic antagonists/agonists of the corticotropin-releasing factor receptor (crfr) |
| 03/28/2002 | WO2002024731A2 Regulation of human fgd1-like protein |
| 03/28/2002 | WO2002024729A2 Haemophilus influenzae basb202 polypeptide, production, vaccine and diagnostic use |
| 03/28/2002 | WO2002024727A2 New inhibitors of iapp fibril formation and uses thereof |
| 03/28/2002 | WO2002024726A2 Olfactory and pheromones g-protein coupled receptors |
| 03/28/2002 | WO2002024723A1 Modified factor viii |
| 03/28/2002 | WO2002024721A1 21 human secreted proteins |
| 03/28/2002 | WO2002024720A1 Antisense modulation of caspase 2 expression |
| 03/28/2002 | WO2002024719A1 21 human secreted proteins |
| 03/28/2002 | WO2002024718A1 Compositions and methods relating to prostate specific genes and proteins |
| 03/28/2002 | WO2002024717A1 Antisense modulation of flip-c expression |
| 03/28/2002 | WO2002024647A1 Ep4 receptor agonists containing 8-azaprostaglandin derivatives as the active ingredient |
| 03/28/2002 | WO2002024239A1 Method and hemostatic patch for effecting local hemostasis |
| 03/28/2002 | WO2002024235A2 Prochelators of radiometal labeled molecules |
| 03/28/2002 | WO2002024234A2 Use of recombinant gene delivery vectors for treating or preventing diseases of the eye |
| 03/28/2002 | WO2002024233A2 Control of nk cell function and survival by modulation of ship activity |
| 03/28/2002 | WO2002024229A1 Method of regulating osteoclast formation |
| 03/28/2002 | WO2002024228A1 Method of regulating osteoclast formation |
| 03/28/2002 | WO2002024222A2 Ligands for g protein coupled receptors and methods of using them |
| 03/28/2002 | WO2002024221A2 Notch receptor agonists and uses |
| 03/28/2002 | WO2002024219A1 Growth factor complex |
| 03/28/2002 | WO2002024218A1 Angiogenic agents and their uses |
| 03/28/2002 | WO2002024217A1 Use of il-8 protein modulators in the treatment of viral infections |
| 03/28/2002 | WO2002024216A2 Method for use of igf-binding protein for selective sensitization of target cells in vivo |
| 03/28/2002 | WO2002024215A2 Method for using activated protein c for the treatment of coagulation-associated disorders |
| 03/28/2002 | WO2002024214A2 Use of glp -2 in combination with another therapeutic agent in bone-related and nutrition-related disorders |
| 03/28/2002 | WO2002024213A2 Improved protocol for paracentesis |
| 03/28/2002 | WO2002024192A1 Dipeptide ligands of the npff receptor for treating pain and hyperalgesia |
| 03/28/2002 | WO2002024177A2 Methods of identifying inhibitory compounds and uses thereof |
| 03/28/2002 | WO2002024176A2 Treatment of tinnitus |
| 03/28/2002 | WO2002024148A2 Method or treatment of tumors using transforming growth factor-alpha |
| 03/28/2002 | WO2002024144A2 Use of transcription factors for treating inflammation and other diseases |
| 03/28/2002 | WO2002024057A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 03/28/2002 | WO2002023995A1 Method of blocking free radical processes which result in media ted pathology without deleterious pro-oxidant side reactions |
| 03/28/2002 | WO2002015882A8 Delayed release compositions and combinations |
| 03/28/2002 | WO2002011743A3 Treatment of prostate cancer |
| 03/28/2002 | WO2002005748A3 Medicinal uses of mu-opioid receptor agonists |
| 03/28/2002 | WO2002002595A9 Amphipathic linear peptides and compositions containing same |
| 03/28/2002 | WO2001098333A3 Modification of hepatitis b core antigen |
| 03/28/2002 | WO2001091785A3 Use of hyaluronidase for preventing and treating cardio vascular diseases |
| 03/28/2002 | WO2001090144A3 Vip-related peptides for the treatment of sexual disorders in women |
| 03/28/2002 | WO2001089479A3 Sustained release pharmaceutical compositions for parenteral administration of hydrophilic compounds |
| 03/28/2002 | WO2001088091A3 Novel bone marrow nucleic acids and polypeptides |
| 03/28/2002 | WO2001087939A3 Genes required for natural competence, proteins, and their use |
| 03/28/2002 | WO2001087321A3 Glycosyltransferase proteins |
| 03/28/2002 | WO2001085964A3 Over expression of the whn protein |
| 03/28/2002 | WO2001085904A3 A novel polypeptide--- a human protein 9 containing the fragment of prion characteristic sequence and polynucleotide encoding it |
| 03/28/2002 | WO2001085781A3 Repair of nerve damage |
| 03/28/2002 | WO2001085762B1 Cancer diagnosis and assays for screening anti-cancer agents |
| 03/28/2002 | WO2001083522A3 Growth factor modified protein matrices for tissue engineering |
| 03/28/2002 | WO2001081570A3 Heteromultimeric ion channel receptor and uses thereof |
| 03/28/2002 | WO2001081410A3 G protein-coupled receptors |
| 03/28/2002 | WO2001079459A3 Polypeptides having haloperoxidase activity |
| 03/28/2002 | WO2001079449A3 Novel nucleic acids and polypeptides |
| 03/28/2002 | WO2001078774A3 Recombinant intracellular pathogen vaccines and methods for use |
| 03/28/2002 | WO2001078706A3 Treatment of hyperproliferative, inflammatory and related mucocutaneous disorders using inhibitors of mevalonate synthesis and metabolism |
| 03/28/2002 | WO2001078653A3 Graft rejection inhibition with ccr2 inhibitors |
| 03/28/2002 | WO2001077286A3 A novel polypeptide, human uterine globine 58 and the polynucleotide encoding the polypeptide |
| 03/28/2002 | WO2001077170A3 Multiprotein-complexes comprising a nmda receptor and uses thereof |
| 03/28/2002 | WO2001076575A3 The treatment of respiratory diseases |
| 03/28/2002 | WO2001075105A3 Human leucine-rich repeat family member and uses thereof |
| 03/28/2002 | WO2001075045A3 A novel polypeptide - human clathrin light chain 17 and the polynucleotide encoding said polypeptide |
| 03/28/2002 | WO2001074859A3 A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 03/28/2002 | WO2001073026A3 43238, a novel g protein-coupled receptor and uses therefor |
| 03/28/2002 | WO2001072327A3 Use of analogues of superoxide dismutase for treating hepatocellular insufficiencies |
| 03/28/2002 | WO2001072279A3 Medical emulsion for lubrication and delivery of drugs |